1 of 1
HOUSE DOCKET, NO. 1745 FILED ON: 1/18/2023
HOUSE . . . . . . . . . . . . . . . No. 1053
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Bradley H. Jones, Jr.
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act establishing a commission to study the promotion of preferred pharmacy networks.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Bradley H. Jones, Jr.20th Middlesex1/17/2023Nicholas A. Boldyga3rd Hampden1/26/2023Susan Williams Gifford2nd Plymouth1/26/2023F. Jay Barrows1st Bristol1/26/2023Paul K. Frost7th Worcester1/31/2023Kimberly N. Ferguson1st Worcester2/1/2023 1 of 2
HOUSE DOCKET, NO. 1745 FILED ON: 1/18/2023
HOUSE . . . . . . . . . . . . . . . No. 1053
By Representative Jones of North Reading, a petition (accompanied by bill, House, No. 1053) of
Bradley H. Jones, Jr. and others relative to establishing a commission (including members of the
General Court) to study the promotion of preferred pharmacy networks where insurers can
negotiate lower drug prices. Financial Services.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1124 OF 2021-2022.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act establishing a commission to study the promotion of preferred pharmacy networks.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Notwithstanding any general or special law to the contrary, there shall be a
2commission to study the implementation of preferred pharmacy networks, whereby health
3insurers steer consumers to lower-cost “preferred” pharmacies where insurers can negotiate
4lower drug prices.
5 SECTION 2. The commission shall consist of the house and senate chairs of the joint
6committee on health care financing, who shall serve as the co-chairs; one member to be
7appointed by the speaker of the house of representatives; one member to be appointed by the
8president of the senate; one member to be appointed by the house minority leader; one member
9to be appointed by the senate minority leader; the director of the health policy commission or a 2 of 2
10designee; the commissioner of the department of public health or a designee; and the executive
11director of the center for health information and analysis or a designee.
12 SECTION 3. The commission shall study the feasibility of implementing preferred
13pharmacy networks and make recommendations based on a cost-benefit analysis of such
14networks. The commission shall provide estimates of projected savings in prescription drug costs
15from implementing such networks.
16 SECTION 4. The commission shall submit its report and findings, along with any
17recommendations and drafted legislation, to the house and senate committees on ways and
18means, the joint committee on health care financing, and the clerks of the house of
19representatives and senate within 12 months of the passage of this act.